Latest filing published 10 Feb 2026 for Arch Biopartners Inc., €44k.
Richard Lawrence Rossman discloses dealings in Arch Biopartners Inc. to SEDI. Over a trading history stretching from 13 April 2023 to 2 February 2026, the count stands at 4 filings.
The open-market record consists of 3 sales worth €169k, with no purchase. Outside the open market, there are 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 10 February 2026 with an open-market sale (€44k) in Arch Biopartners Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations